217 results on '"Iannicelli E"'
Search Results
2. [18F]FDG-PET/CT and long-term responses to everolimus in advanced neuroendocrine neoplasia
3. CT-based radiomics for prediction of therapeutic response to Everolimus in metastatic neuroendocrine tumors
4. Is CT radiomics superior to morphological evaluation for PN0 characterization? A pilot study in stage II colon adenocarcinoma
5. MRI techniques for the evaluation on liver fat content: comparison between different techniques
6. [18F]FDG-PET/CT and long-term response to everolimus in advanced neuroendocrine neoplasia
7. P-214 Utility of “pseudo-adjuvant” chemotherapy (CT) in metastatic colorectal cancer (mCRC): A monocentric multidisciplinary experience
8. 3D pelvimetry and biometric measurements: a surgical perspective for colorectal resections
9. Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma
10. The rate of pancreatic abnormalities detected by magnetic resonance in high risk individuals under surveillance for tthe risk of pancreatic cancer is not different from that of controls
11. 1185P [18F]FDG-PET/CT and long-term response to everolimus in advanced neuroendocrine neoplasia
12. [18F]FDG-PET/CT and long-term responses to everolimus in advanced neuroendocrine neoplasia
13. Diffusion magnetic resonance in cervical carcinoma. The role of apparent diffusion coefficient in the evaluation of treatment response
14. Integrated diagnostic imaging of primary thoracic rhabdomyosarcoma
15. Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms
16. Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications
17. Tubercular epididymitis and orchitis: US patterns
18. P.03.1 PROGNOSTIC IMPACT OF TUMOR BURDEN IN STAGE IV NEUROENDOCRINE NEOPLASIA: COMPARISON BETWEEN PANCREATIC AND GASTROINTESTINAL LOCALIZATIONS
19. P.03.12 TEXTURE ANALYSIS ON CONTRAST-ENHANCED COMPUTED TOMOGRAPHY IN LIVER METASTASES FROM PANCREATIC AND NON-PANCREATIC NEUROENDOCRINE NEOPLASIA
20. OC.02.5 THE RATE OF PANCREATIC ABNORMALITIES DETECTED BY MAGNETIC RESONANCE IN HIGH RISK INDIVIDUALS UNDER SURVEILLANCE FOR THE RISK OF PANCREATIC CANCER IS NOT DIFFERENT FROM THAT OF CONTROLS
21. 3D MRI segmentation and 3D circumferential resection margin evaluation for a standard rectal cancer assessment
22. P.04.12 ROLE OF CYST FEATURES AND PATIENTS' FACTORS IN PREDICTING THE RISK OF PROGRESSION IN BD-IPMN UNDERGOING FOLLOW-UP
23. Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
24. Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib
25. Bone mass and bone turnover in harmodialized and transplanted patients
26. endocrine and neuroendocrine tumours 18F-FDG-PET to predict disease progression in advanced digestive neuroendocrine neoplasms
27. Reassessment of proliferative activity at disease progression in neuroendocrine neoplasms
28. P.02.4 REASSESSMENT OF HISTOLOGICAL FEATURES AT DISEASE PROGRESSION DURING THE FOLLOW-UP OF NEUROENDOCRINE TUMOURS
29. Evaluation of HCC and hypovascular nodules with gadoxetic acid-enhanced MRI and DWI
30. 3D MRI segmentation and 3D circumferential resection margin evaluation for a standard rectal cancer assessment.
31. A real-world analysis of the outcome of patients with IPMN and indication for surgery according to IAP criteria in whom surgery is not performed due to advanced age or comorbidities
32. P-117 Sarcopenia at First Diagnosis Predicts a Reduced Survival in Patients Affected by Hepatocarcinoma
33. P0367 : Sarcopenia is associated with a reduced survival in patients with hepatocarcinoma undergoing sorafenib treatment
34. Sarcopenia at First Diagnosis Predicts a Reduced Survival in Patients Affected by Hepatocarcinoma
35. SARCOPENIA IS ASSOCIATED WITH A REDUCED SURVIVAL IN PATIENTS WITH HEPATOCARCINOMA UNDERGOING SORAFENIB TREATMENT
36. TOTAL MESORECTAL EXCISION FOR RECTAL CANCER: OUR SINGLE CENTRE 10 YEARS EXPERIENCE
37. A pancreatico-pleural fistula diagnosed with magnetic resonance cholangiopancreatography
38. [Role of color Doppler US in the evaluation of renal transplant]
39. [Comprehensive imaging of hepatic adenoma simulating focal nodular hyperplasia. A case report]
40. [Role of color Doppler echography in the visualization of perianal fistulae with injections of physiologic solutions]
41. [A case of nodular fasciitis of the tensor muscle of the fascia lata]
42. [Multiple prostatic biopsies in the 'gray zone' of the specific prostatic antigen]
43. 1606P - endocrine and neuroendocrine tumours 18F-FDG-PET to predict disease progression in advanced digestive neuroendocrine neoplasms
44. 436P - Reassessment of proliferative activity at disease progression in neuroendocrine neoplasms
45. [A case of the adult respiratory distress syndrome induced by a methadone overdose]
46. P.10.13 INCIDENTALLY DIAGNOSED IPMNs IN LIVER CIRRHOSIS: PREVALENCE AND CLINICAL RELEVANCE
47. P.10.20 ROLE OF SOMATOSTATIN RECEPTORS SCINTIGRAPHY IN NEUROENDOCRINE NEOPLASMS FOLLOW-UP
48. Role of somatostatin receptors scintigraphy in neuroendocrine neoplasms follow-up
49. Metastatic pattern differently affects progression-free survival in pancreatic neuroendocrine tumors
50. A real-world analysis of the outcome of patients with IPMN and indication for surgery according to IAP criteria in whom surgery is not performed due to advanced age and/or comorbidities
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.